The study identifies TRAM as a fourth TIR domain-containing adaptor protein involved in Toll receptor signaling, functioning alongside TRIF in activating IRF-3, IRF-7, and NF-κB pathways. TRAM is specifically involved in the LPS-TLR4 signaling pathway, whereas TRIF is involved in both TLR3 and TLR4 pathways. TRAM interacts with TRIF, MyD88-like protein (Mal)/TIRAP, and TLR4 but not TLR3. These findings suggest that TRAM and TRIF both function in LPS-TLR4 signaling to regulate the MyD88-independent pathway during the innate immune response to LPS. TRAM activates NF-κB and IRF-3/7, similar to TRIF. TRAM is required for LPS signaling, while TRIF is required for signaling by both TLR3 and TLR4. Both TRAM and TRIF interact with Mal/TIRAP, and TRAM is specifically involved in the TLR4 pathway. The study also shows that TRAM and TRIF are essential for TLR4 signaling, and their interaction with TLR4 is critical for the signaling pathway. The results indicate that TRAM and TRIF are important components of the IRF3 signaling pathway and suggest that these adaptor proteins form a multiprotein complex with IRF3/7, CBP, and the IRF-3/7 kinases (IKKε and TBK1) during signal transduction. The study also demonstrates that TRAM is required for the activation of the IRF pathway in the TLR4 but not the TLR3 signaling pathway. TRAM also activates NF-κB, and its function is specific to the TLR4 pathway. The study concludes that TRAM and TRIF are essential for TLR4 signaling, and their interaction with TLR4 is critical for the signaling pathway.The study identifies TRAM as a fourth TIR domain-containing adaptor protein involved in Toll receptor signaling, functioning alongside TRIF in activating IRF-3, IRF-7, and NF-κB pathways. TRAM is specifically involved in the LPS-TLR4 signaling pathway, whereas TRIF is involved in both TLR3 and TLR4 pathways. TRAM interacts with TRIF, MyD88-like protein (Mal)/TIRAP, and TLR4 but not TLR3. These findings suggest that TRAM and TRIF both function in LPS-TLR4 signaling to regulate the MyD88-independent pathway during the innate immune response to LPS. TRAM activates NF-κB and IRF-3/7, similar to TRIF. TRAM is required for LPS signaling, while TRIF is required for signaling by both TLR3 and TLR4. Both TRAM and TRIF interact with Mal/TIRAP, and TRAM is specifically involved in the TLR4 pathway. The study also shows that TRAM and TRIF are essential for TLR4 signaling, and their interaction with TLR4 is critical for the signaling pathway. The results indicate that TRAM and TRIF are important components of the IRF3 signaling pathway and suggest that these adaptor proteins form a multiprotein complex with IRF3/7, CBP, and the IRF-3/7 kinases (IKKε and TBK1) during signal transduction. The study also demonstrates that TRAM is required for the activation of the IRF pathway in the TLR4 but not the TLR3 signaling pathway. TRAM also activates NF-κB, and its function is specific to the TLR4 pathway. The study concludes that TRAM and TRIF are essential for TLR4 signaling, and their interaction with TLR4 is critical for the signaling pathway.